OM1, a Boston, MA-based healthcare outcome analytics company, closed a $15M Series A financing round.
The round was led by General Catalyst with participation from Glikvest, 7wire Ventures and Wanxiang Healthcare Investments.
The company intends to use the funds to continue the buildout of its tech platform.
Led by Rich Gliklich, founder and CEO, OM1 leverages big data and artificial intelligence (AI) to provide stakeholders with an analytics platform to have a holistic view and better understanding of real-world healthcare outcomes for better decision-making.
The system gathers, synthesizes, enriches, and leverages clinical data to provide measurements and AI-driven insights and predictions that can improve clinical, financial, and operational management. The system’s analytics can help healthcare organizations better optimize care for both individuals and populations, can inform smart supply chain decisions, and can provide a clearer link between outcomes and value.